These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 8631017

  • 1. Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase C.
    Zhang X, Zhang R, Zhao H, Cai H, Gush KA, Kerr RG, Pettit GR, Kraft AS.
    Cancer Res; 1996 Feb 15; 56(4):802-8. PubMed ID: 8631017
    [Abstract] [Full Text] [Related]

  • 2. In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity.
    Berkow RL, Schlabach L, Dodson R, Benjamin WH, Pettit GR, Rustagi P, Kraft AS.
    Cancer Res; 1993 Jun 15; 53(12):2810-5. PubMed ID: 8504423
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM, Wall NR, Dutcher JA, Al-Katib AM.
    Clin Cancer Res; 2000 Dec 15; 6(12):4950-6. PubMed ID: 11156256
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI, Orr RM, Goddard PM, Lacey HA, Lancashire H, Judson IR, Beck T, Bryan B, Cotter FE.
    J Pharmacol Exp Ther; 1997 Apr 15; 281(1):420-7. PubMed ID: 9103525
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
    Cragg LH, Andreeff M, Feldman E, Roberts J, Murgo A, Winning M, Tombes MB, Roboz G, Kramer L, Grant S.
    Clin Cancer Res; 2002 Jul 15; 8(7):2123-33. PubMed ID: 12114412
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study.
    Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR.
    Clin Cancer Res; 2003 Jan 15; 9(1):109-14. PubMed ID: 12538458
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
    Foster BJ, Wiegand RA, LoRusso PM, Baker LH.
    Clin Cancer Res; 1995 Aug 15; 1(8):831-7. PubMed ID: 9816052
    [Abstract] [Full Text] [Related]

  • 17. A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study.
    Weitman S, Langevin AM, Berkow RL, Thomas PJ, Hurwitz CA, Kraft AS, Dubowy RL, Smith DL, Bernstein M.
    Clin Cancer Res; 1999 Sep 15; 5(9):2344-8. PubMed ID: 10499603
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.
    Kumar V, Schuck EL, Pelletier RD, Farah N, Condon KB, Ye M, Rowbottom C, King BM, Zhang ZY, Saxton PL, Wong YN.
    Cancer Chemother Pharmacol; 2012 Jan 15; 69(1):229-37. PubMed ID: 21698359
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
    Brunner F, Kolmayr U, Kukovetz WR.
    Arzneimittelforschung; 1989 Nov 15; 39(11):1430-5. PubMed ID: 2619776
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
    Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, Lawal YM, Cogburn JN, Gresk CJ, Markos CS, Maziasz TJ, Schoenhard GL, Burton EG.
    Drug Metab Dispos; 2000 May 15; 28(5):514-21. PubMed ID: 10772629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.